|

TPC Clinical Trials

5 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 2: 3Phase 3: 1

Top Sponsors

  • Fudan University2
  • Wenjin Yin1
  • Memorial Sloan Kettering Cancer Center1
  • Henan Cancer Hospital1

Indications

  • Breast Cancer5
  • Cancer5
  • Advanced Breast Cancer3
  • Hormone Receptor Positive Tumor1
  • Metastatic Breast Cancer1

Other4 trials

A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer
Phase 2
Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer
N/A
Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer
Phase 3
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Phase 2

Birmingham, Alabama1 trial

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.